FindTrial
Sign In

Effect of Vitamin D supplementation in Rheumatoid Arthritis

Effect of Vitamin D supplementation in Rheumatoid Arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033032
Enrollment
90
Registered
2021-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

Intervention1: Vitamin D: Vitamin D 60000 IU once weekly for 6 weeks Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Sponsors

All India Institute of Medical Sciences Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consenting adult patients with active rheumatoid arthritis (2010 ACR/EULAR criteria) on stable treatment for last 3 months

Exclusion criteria

Exclusion criteria: 1. Overlap of rheumatoid arthritis and other autoimmune diseases, 2. Abnormal serum calcium, phosphorus, alkaline phosphatase ( > 2x ULN) 3. Vitamin D toxicity ( > 150 ng/ml) [28] 4. Refusal of consent

Design outcomes

Primary

MeasureTime frame
To assess the absolute change in CDAI values in participants receiving standard treatment along with vitamin D (60,000 IU/week x 6 weeks)Timepoint: Day 1 and day 90—

Secondary

MeasureTime frame
To assess change in quality of life using Indian HAQ, WHO-QOL BREF questionnairesTimepoint: Day 1 and Day 90;To assess effect of vitamin D supplementation on disease severity of fibromyalgiaTimepoint: Day 1 and Day 90;To assess pain relief using change in visual analog scoresTimepoint: Day 1 and Day 90;To assess proportion of participants achieving remission according to EULAR remission criteria (CDAI 2.8)Timepoint: Day 1 and Day 90—

Countries

India

Contacts

Public ContactDr Arnav Kalra

All India Institute of Medical Sciences Rishikesh

arnavjr.med@aiimsrishikesh.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 24, 2026